Literature DB >> 8341305

Significant improvement of stiff-person syndrome after paraspinal injection of botulinum toxin A.

D Davis1, B Jabbari.   

Abstract

Following several months of low back pain, a 36-year-old man developed progressive stiffness of the abdominal, low back, and thigh muscles. On examination, these muscles demonstrated marked hypertonia consistent with the clinical diagnosis of stiff-person syndrome. The patient demonstrated increased lumbar lordosis and had focal hyperhidrosis at different sites. Electromyography showed continuous activity of the paraspinal and thigh muscles, and serum and cerebrospinal fluid antibodies to glutamic acid decarboxylase (GAD) were markedly elevated. Diazepam and Lioresal offered partial pain relief. Paraspinal muscle administration of botulinum toxin A reduced the tone of paraspinal and thigh muscles significantly and resulted in marked improvement of ambulation and cessation of pain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8341305     DOI: 10.1002/mds.870080323

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  5 in total

1.  Stiff-man syndrome.

Authors:  H U Rehman
Journal:  Postgrad Med J       Date:  1998-11       Impact factor: 2.401

Review 2.  Botulinum toxin in clinical practice.

Authors:  J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

3.  Costs of treating dystonias and hemifacial spasm with botulinum toxin A.

Authors:  R C Dodel; A Kirchner; R Koehne-Volland; G Künig; A Ceballos-Baumann; M Naumann; A Brashear; H P Richter; T D Szucs; W H Oertel
Journal:  Pharmacoeconomics       Date:  1997-12       Impact factor: 4.981

4.  Stiff-person Syndrome.

Authors:  Olavo M. Vasconcelos; Marinos C. Dalakas
Journal:  Curr Treat Options Neurol       Date:  2003-01       Impact factor: 3.598

5.  Utility of Botulinum Injections in Stiff-Person Syndrome.

Authors:  L M Conners; A Betcher; A Shahinian; P Janda
Journal:  Case Rep Neurol Med       Date:  2019-10-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.